ROBINSON JAMES GEORGE purchased 0.3% of their position (9K shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $15.0K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/19/2019ACC: 0001651844-19-000012
Director
Since Oct 2018
+9K
Net shares
Net buyer
$15.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
9K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+100.00
Price / share
$1.65
Trade value
$165.18
% of position
0.0%
6/18/2019
3.41M→3.41M
Common Stock
Direct
Shares
+8.90K
Price / share
$1.67
Trade value
$14.88K
% of position
0.3%
6/18/2019
3.41M→3.42M
Total
Net shares
+9K
Net value
$15.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/18/2019 | P · Purchase | +100.00 | $1.65 | $165.18 | 0.0% | 3.41M | 3.41M |
| Common Stock Direct | 6/18/2019 | P · Purchase | +8.90K | $1.67 | $14.88K | 0.3% | 3.41M | 3.42M |
| Total | +9K | $15.05K | ||||||
Derivative Transactions0
No derivative transactions reported